Gui Y - Search Results

1

Global Proteome and Phosphoproteome Characterization of Sepsis-induced Kidney Injury.

Lin YH, Platt MP, Fu H, Gui Y, Wang Y, Gonzalez-Juarbe N, Zhou D, Yu Y. Lin YH, et al. Among authors: gui y. Mol Cell Proteomics. 2020 Dec;19(12):2030-2047. doi: 10.1074/mcp.RA120.002235. Epub 2020 Sep 22. Mol Cell Proteomics. 2020. PMID: 32963032 Free PMC article.

2

[No title available]

[No authors listed] [No authors listed] PMID: 33451636

3

The hepatocyte growth factor/c-met pathway is a key determinant of the fibrotic kidney local microenvironment.

Fu H, Gui Y, Liu S, Wang Y, Bastacky SI, Qiao Y, Zhang R, Bonin C, Hargis G, Yu Y, Kreutzer DL, Biswas PS, Zhou Y, Wang Y, Tian XJ, Liu Y, Zhou D. Fu H, et al. Among authors: gui y. iScience. 2021 Sep 9;24(10):103112. doi: 10.1016/j.isci.2021.103112. eCollection 2021 Oct 22. iScience. 2021. PMID: 34622165 Free PMC article.

4

Serum integrative omics reveals the landscape of human diabetic kidney disease.

Liu S, Gui Y, Wang MS, Zhang L, Xu T, Pan Y, Zhang K, Yu Y, Xiao L, Qiao Y, Bonin C, Hargis G, Huan T, Yu Y, Tao J, Zhang R, Kreutzer DL, Zhou Y, Tian XJ, Wang Y, Fu H, An X, Liu S, Zhou D. Liu S, et al. Among authors: gui y. Mol Metab. 2021 Dec;54:101367. doi: 10.1016/j.molmet.2021.101367. Epub 2021 Nov 1. Mol Metab. 2021. PMID: 34737094 Free PMC article. Clinical Trial.

5

Effects of SGLT2 Inhibitors on Renal Outcomes in Patients With Chronic Kidney Disease: A Meta-Analysis.

Li N, Lv D, Zhu X, Wei P, Gui Y, Liu S, Zhou E, Zheng M, Zhou D, Zhang L. Li N, et al. Among authors: gui y. Front Med (Lausanne). 2021 Nov 1;8:728089. doi: 10.3389/fmed.2021.728089. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34790672 Free PMC article.

6

Non-canonical Wnt/calcium signaling is protective against podocyte injury and glomerulosclerosis.

Zhou D, Wang Y, Gui Y, Fu H, Zhou S, Wang Y, Bastacky SI, Stolz DB, Liu Y. Zhou D, et al. Among authors: gui y. Kidney Int. 2022 Jul;102(1):96-107. doi: 10.1016/j.kint.2022.02.029. Epub 2022 Mar 24. Kidney Int. 2022. PMID: 35341792 Free PMC article.

7

Editorial: Tissue microenvironment in kidney diseases.

Gui Y, Liu S, Fu H, Zhou D. Gui Y, et al. Front Med (Lausanne). 2023 Feb 6;10:1134043. doi: 10.3389/fmed.2023.1134043. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36814777 Free PMC article. No abstract available.

8

Acute kidney injury in diabetes mellitus: Epidemiology, diagnostic, and therapeutic concepts.

Gui Y, Palanza Z, Fu H, Zhou D. Gui Y, et al. FASEB J. 2023 Apr;37(4):e22884. doi: 10.1096/fj.202201340RR. FASEB J. 2023. PMID: 36943403 Free PMC article. Review.

9

Limonin, a natural ERK2 agonist, protects against ischemic acute kidney injury.

Zhou X, Xiang Y, Li D, Zhong M, Hong X, Gui Y, Min W, Chen Y, Zeng X, Zhu H, Liu Y, Liu S, Yang P, Hou F, Zhou D, Fu H. Zhou X, et al. Among authors: gui y. Int J Biol Sci. 2023 May 29;19(9):2860-2878. doi: 10.7150/ijbs.82417. eCollection 2023. Int J Biol Sci. 2023. PMID: 37324945 Free PMC article.

10

Blockade of CD38 diminishes lipopolysaccharide-induced macrophage classical activation and acute kidney injury involving NF-κB signaling suppression.

Shu B, Feng Y, Gui Y, Lu Q, Wei W, Xue X, Sun X, He W, Yang J, Dai C. Shu B, et al. Among authors: gui y. Cell Signal. 2018 Jan;42:249-258. doi: 10.1016/j.cellsig.2017.10.014. Epub 2017 Nov 12. Cell Signal. 2018. PMID: 29080804

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,298 results

Search Page

Filters